Insider trading

Period: 120 months Stock: IRWD + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

226 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

226 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

226 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

226 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
226 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
226 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

226 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
7 Jul 2026
Silver Ronald PFO & PAO
Sold on a plan
$578.06K 127,890 at 4.52
29.0%
Planned (10b5-1)
16 Jun 2026
McHugh Julie Director
Sold on a plan
$80.46K 21,571 at 3.73
7.9%
Planned (10b5-1)
17 Mar 2026
DENNER ALEXANDER J Director · indirect
Sold at will 2×
$20.53M 6,730,800 at 3.05
42.3%
Not planned
24 Feb 2026
MCCOURT Thomas A Chief Executive Officer
Sold at will
$378.91K 103,526 at 3.66
6.5%
Not planned
24 Feb 2026
John Minardo Chief Legal Officer
Sold at will
$69.73K 19,053 at 3.66
5.0%
Not planned
24 Feb 2026
Shetzline Michael SVP, CMO, Head-Res&Drug
Bought
$62.26K 17,012 at 3.66
3.4%
First buy on file
24 Feb 2026
Silver Ronald Principal Accounting Officer
Sold at will
$46.19K 12,621 at 3.66
4.8%
Not planned
24 Feb 2026
Martini Gregory S. Chief Financial Officer
Sold at will
$41.93K 11,457 at 3.66
6.7%
Not planned
24 Feb 2026
Gaskins Tammi L Chief Commercial Officer
Sold at will
$41.13K 11,239 at 3.66
5.0%
Not planned
23 Feb 2026
MCCOURT Thomas A Chief Executive Officer
Sold at will
$361.02K 94,757 at 3.81
5.6%
Not planned
23 Feb 2026
John Minardo Chief Legal Officer
Sold at will
$66.44K 17,439 at 3.81
4.4%
Not planned
23 Feb 2026
Shetzline Michael SVP, CMO, Head-Res&Drug
Sold at will
$59.32K 15,570 at 3.81
2.8%
Not planned
23 Feb 2026
Silver Ronald Principal Accounting Officer
Sold at will
$44.01K 11,552 at 3.81
4.2%
Not planned
23 Feb 2026
Martini Gregory S. Chief Financial Officer
Sold at will
$39.96K 10,487 at 3.81
5.7%
Not planned
23 Feb 2026
Gaskins Tammi L Chief Commercial Officer
Sold at will
$39.19K 10,287 at 3.81
4.4%
Not planned
5 Jan 2026
Silver Ronald Principal Accounting Officer
Sold on a plan
$162.91K 35,416 at 4.60
11.3%
Planned (10b5-1)
17 Nov 2025
Gaskins Tammi L Chief Commercial Officer
Sold at will
$19.97K 6,016 at 3.32
2.5%
Not planned
11 Aug 2025
John Minardo Chief Legal Officer
Sold at will
$6.51K 7,754 at 0.84
1.9%
Not planned
11 Aug 2025
Silver Ronald Principal Accounting Officer
Sold at will
$2.39K 2,846 at 0.84
1.0%
Not planned
11 Aug 2025
Gaskins Tammi L Chief Commercial Officer
Sold at will
$1.11K 1,316 at 0.84
0.5%
Not planned
11 Aug 2025
Martini Gregory S. Chief Financial Officer
Sold at will
$1.06K 1,265 at 0.84
0.7%
Not planned
16 May 2025
MCCOURT Thomas A Chief Executive Officer
Sold at will
$7.74K 13,353 at 0.58
1.2%
Not planned
16 May 2025
Gaskins Tammi L Chief Commercial Officer
Sold at will
$1.49K 2,563 at 0.58
1.0%
Not planned
10 Feb 2025
MCCOURT Thomas A Chief Executive Officer
Sold at will
$244.75K 139,064 at 1.76
10.7%
Not planned
10 Feb 2025
Shetzline Michael SVP, CMO, Head-Res&Drug
Sold at will
$72.63K 41,269 at 1.76
6.9%
Not planned
10 Feb 2025
John Minardo Chief Legal Officer
Sold at will
$68.53K 38,938 at 1.76
8.7%
Not planned
10 Feb 2025
Martini Gregory S. Chief Financial Officer
Sold at will
$21.21K 12,052 at 1.76
6.2%
Not planned
10 Feb 2025
Silver Ronald Principal Accounting Officer
Sold at will
$21.20K 12,048 at 1.76
4.1%
Not planned
18 Nov 2024
Emany Sravan Kumar SVP, COO and CFO
Sold at will
$44.88K 11,001 at 4.08
3.4%
Not planned
18 Nov 2024
Davis Andrew SVP, Chief Business Officer
Sold at will
$21.87K 5,360 at 4.08
1.8%
Not planned
12 Aug 2024
John Minardo Chief Legal Officer
Sold at will
$42.32K 9,910 at 4.27
3.4%
Not planned
12 Aug 2024
Silver Ronald Principal Accounting Officer
Sold at will
$13.27K 3,107 at 4.27
1.9%
Not planned
10 Jun 2024
McHugh Julie Director
Sold on a plan
$143.20K 22,766 at 6.29
14.0%
Planned (10b5-1)
7 Jun 2024
Sold at will
$235.14K 35,574 at 6.61
42.2%
Not planned
6 Jun 2024
Sold at will
$282.55K 44,426 at 6.36
34.5%
Not planned
20 May 2024
MCCOURT Thomas A Chief Executive Officer
Sold at will
$436.14K 67,618 at 6.45
5.6%
Not planned
20 May 2024
Davis Andrew SVP, Chief Business Officer
Sold at will
$146.58K 22,725 at 6.45
7.3%
Not planned
20 May 2024
John Minardo Chief Legal Officer
Sold at will
$112.26K 17,404 at 6.45
5.6%
Not planned
20 May 2024
Shetzline Michael CMO,SVP,Head-Res&Drug
Sold at will
$104.03K 16,128 at 6.45
3.8%
Not planned
6 Mar 2024
Duane Jon R Director
Bought
$60.20K 6,920 at 8.70
6.1%
First buy on file
4 Mar 2024
Emany Sravan Kumar SVP, Chief Financial Officer
Bought
$100.22K 10,684 at 9.38
3.7%
12 Feb 2024
MCCOURT Thomas A Chief Executive Officer
Sold at will
$2.70M 177,164 at 15.24
17.5%
Not planned
12 Feb 2024
John Minardo Chief Legal Officer
Sold at will
$722.07K 47,380 at 15.24
17.4%
Not planned
12 Feb 2024
Shetzline Michael CMO,SVP,Head-Res&Drug
Sold at will
$588.54K 38,618 at 15.24
10.2%
Not planned
12 Feb 2024
Davis Andrew SVP, Chief Business Officer
Sold at will
$150.05K 9,846 at 15.24
4.5%
Not planned
12 Feb 2024
Silver Ronald Principal Accounting Officer
Sold at will
$120.52K 7,908 at 15.24
5.6%
Not planned
14 Dec 2023
Kessler Marla L Director
Sold on a plan
$111.07K 9,926 at 11.19
9.3%
Planned (10b5-1)
20 Nov 2023
Davis Andrew SVP, Chief Business Officer
Sold at will
$31.85K 3,287 at 9.69
1.5%
Not planned
15 Sep 2023
Emany Sravan Kumar SVP, Chief Financial Officer
Bought
$300.12K 36,072 at 8.32
23.6%
First buy on file
14 Aug 2023
John Minardo Chief Legal Officer
Sold at will
$70.73K 7,045 at 10.04
3.5%
Not planned
Showing 1–50 of 226. Page 1 of 5 Older →